These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12593851

  • 1. Heparin inhibits SMC growth in the presence of human and fetal bovine serum.
    Cindhuchao N, Quinn DA, Garg HG, Hales CA.
    Biochem Biophys Res Commun; 2003 Feb 28; 302(1):84-8. PubMed ID: 12593851
    [Abstract] [Full Text] [Related]

  • 2. Sulfation patterns in heparin and heparan sulfate: effects on the proliferation of bovine pulmonary artery smooth muscle cells.
    Garg HG, Yu L, Hales CA, Toida T, Islam T, Linhardt RJ.
    Biochim Biophys Acta; 2003 Nov 20; 1639(3):225-31. PubMed ID: 14636954
    [Abstract] [Full Text] [Related]

  • 3. Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells requires both N-acetylation and N-sulfonation.
    Longas MO, Garg HG, Trinkle-Pereira JM, Hales CA.
    Carbohydr Res; 2003 Jan 31; 338(3):251-6. PubMed ID: 12543557
    [Abstract] [Full Text] [Related]

  • 4. Effects of heparin on growth factor-induced mitogenic and proliferative responses of rat pulmonary artery smooth muscle cells.
    Wang HL, Kilfeather SA, Martin GR, Page CP.
    Zhongguo Yao Li Xue Bao; 1997 Sep 31; 18(5):397-400. PubMed ID: 10322925
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of three commercial heparins on Na+/H+ exchange and growth of PASMC.
    Dahlberg CG, Thompson BT, Joseph PM, Garg HG, Spence CR, Quinn DA, Bonventre JV, Hales CA.
    Am J Physiol; 1996 Feb 31; 270(2 Pt 1):L260-5. PubMed ID: 8779995
    [Abstract] [Full Text] [Related]

  • 6. Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells.
    Garg HG, Thompson BT, Hales CA.
    Am J Physiol Lung Cell Mol Physiol; 2000 Nov 31; 279(5):L779-89. PubMed ID: 11053011
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment.
    Mrabat H, Garg HG, Hales CA.
    J Cell Physiol; 2009 Dec 31; 221(3):603-8. PubMed ID: 19653229
    [Abstract] [Full Text] [Related]

  • 8. Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells.
    Wang HL, Kilfeather SA, Martin GR, Page CP.
    Pulm Pharmacol Ther; 2000 Dec 31; 13(2):53-60. PubMed ID: 10799282
    [Abstract] [Full Text] [Related]

  • 9. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
    Reilly CF.
    J Cell Physiol; 1990 Feb 31; 142(2):342-51. PubMed ID: 2154504
    [Abstract] [Full Text] [Related]

  • 10. Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasia.
    McCaffrey TA, Falcone DJ, Borth W, Brayton CF, Weksler BB.
    Biochem Biophys Res Commun; 1992 Apr 30; 184(2):773-81. PubMed ID: 1315533
    [Abstract] [Full Text] [Related]

  • 11. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.
    Reilly CF, Fritze LM, Rosenberg RD.
    J Cell Physiol; 1987 May 30; 131(2):149-57. PubMed ID: 3495540
    [Abstract] [Full Text] [Related]

  • 12. Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers.
    Letourneur D, Logeart D, Avramoglou T, Jozefonvicz J.
    J Biomater Sci Polym Ed; 1993 May 30; 4(5):431-44. PubMed ID: 7694645
    [Abstract] [Full Text] [Related]

  • 13. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum.
    Underwood PA, Mitchell SM, Whitelock JM.
    J Vasc Res; 1998 May 30; 35(6):449-60. PubMed ID: 9858870
    [Abstract] [Full Text] [Related]

  • 14. Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation.
    Joseph PA, Garg HG, Thompson BT, Liu X, Hales CA.
    Biochem Biophys Res Commun; 1997 Dec 08; 241(1):18-23. PubMed ID: 9405227
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells.
    Lee SL, Wang WW, Joseph PM, Hales CA, Fanburg BL.
    Am J Respir Cell Mol Biol; 1997 Jul 08; 17(1):78-83. PubMed ID: 9224212
    [Abstract] [Full Text] [Related]

  • 16. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
    Benitz WE, Lessler DS, Coulson JD, Bernfield M.
    J Cell Physiol; 1986 Apr 08; 127(1):1-7. PubMed ID: 2420809
    [Abstract] [Full Text] [Related]

  • 17. Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin.
    Mori S, Shinohata R, Renbutsu M, Takahashi HK, Fang YI, Yamaoka K, Okamoto M, Yamamoto I, Nishibori M.
    Cell Tissue Res; 2003 Jun 08; 312(3):353-9. PubMed ID: 12764609
    [Abstract] [Full Text] [Related]

  • 18. Heparin inhibits the progression phase of subcultured endothelial cell proliferation in rat aorta.
    Kimura I, Nagaura T, Naitoh T, Kobayashi S, Kimura M.
    Jpn J Pharmacol; 1992 Dec 08; 60(4):369-75. PubMed ID: 1287272
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin.
    Underwood PA, Mitchell SM.
    Cardiovasc Res; 2000 Sep 08; 47(4):749-58. PubMed ID: 10974223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.